StimLabs® Announces Exclusive Distribution Rights for Geistlich's Leading Wound Care Portfolio

New Partnership Expands StimLabs Product Offering to Include Medicare Covered Xenograft, Derma-Gide (Q4203) ROSWELL, Ga., Nov. 26, 2024 /PRNewswire/ -- StimLabs, a leading regenerative medicine company, announced that it has entered into an exclusive national distribution agreement with...